---
title: OB/GYN
---

[![Rosh Review](https://go.roshreview.com/hs-fs/hubfs/RoshReview-Logo-RGB-1.png?width=873&height=139&name=RoshReview-Logo-RGB-1.png "Rosh Review")](https://go.roshreview.com/)

# A is the correct answer

Explanation:

 

Current guidelines for abnormal cervical cancer screening results recommend **equal management for equal risk**. Consequently, **colposcopy**, treatment, or surveillance is based on a patient’s **immediate risk of cervical intraepithelial neoplasia grade 3** or worse **(CIN 3**+**)**, which is determined by a combination of current results and past history. Atypical squamous cells of undetermined significance (ASC-US) are cells with abnormalities that do not show a squamous intraepithelial lesion. Patients with ASC-US who have a positive human papillomavirus (HPV) cotest and unknown previous history of HPV have an immediate risk of CIN 3+ equal to 4.45%. This exceeds the > 4% threshold recommended for management with colposcopy in women who are age ≥ 25.

![](https://roshreview.imgix.net/bbd2122a067dcd0efcdbb4d3bf6c48c2_Image%20-%20Risk%20Based%20Abnormal%20PAP%20Management%20%408x.png?w=4000&fit=max&q=30&auto=compress)

**Proceeding with a loop electrical excision procedure (B)** would be too aggressive for a patient with this level of CIN 3+ risk. The threshold when treatment should be considered is > 25%. **Repeat HPV-based testing in 3 years (C)** would be appropriate management had the patient’s risk been 0.15–0.55%. **Repeat Pap smear in 12 months (D)** is recommended when HPV-based testing is not available.

  

P.S. Want to test your knowledge with more questions like this? Take advantage of **20% off the Rosh Review CREOG Qbank** and get access to 2,000 CREOG-formatted questions with detailed explanations and images!

[![Get 20% Off ](https://no-cache.hubspot.com/cta/default/5087118/c48bf490-385e-4cbf-9e3a-ac0050b24ae5.png)](https://cta-redirect.hubspot.com/cta/redirect/5087118/c48bf490-385e-4cbf-9e3a-ac0050b24ae5)

 

Copyright © 2026 Rosh Review, LLC, 6080 Center Drive Suite 520, Los Angeles, CA 90045

[Terms & Conditions](https://www.roshreview.com/terms-conditions/) | [Disclaimer](https://www.roshreview.com/disclaimer/) | [Privacy Policy](https://www.roshreview.com/privacy-policy/)